Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics and Methotrexate in Psoriasis
NCT07169019Phase 1Recruiting
- Sponsor
- Alexandria University
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by Alexandria University. Primary endpoints: Changes in gut microbiome composition at 16 weeks and Psoriasis Activity and Severity Index at 16 weeks. Started Aug 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07169019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07169019.